BMY
Bristol-Myers Squibb Company
Stock
$61.15−0.31 (−0.50%)Close Oct 2, 2026
- Free cash flow, 2025
- $12.8B
- YoY, 2025
- −7.9%
- 5-year CAGR
- −0.7%
- 10-year CAGR
- +25.9%
Free cash flow
Free cash flow by fiscal year
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $12.8B | −7.9% |
| 2024 | $13.9B | +10.2% |
| 2023 | $12.7B | +5.9% |
| 2022 | $11.9B | −21.6% |
| 2021 | $15.2B | +14.5% |
| 2020 | $13.3B | +80.3% |
| 2019 | $7.4B | +20.6% |
| 2018 | $6.1B | +44.9% |
| 2017 | $4.2B | +129.0% |
| 2016 | $1.8B | +43.4% |
| 2015 | $1.3B | −51.0% |
| 2014 | $2.6B | −12.8% |
| 2013 | $3.0B | −52.9% |
| 2012 | $6.4B | +42.9% |
| 2011 | $4.5B | +10.0% |
| 2010 | $4.1B | +21.9% |
| 2009 | $3.3B | +20.6% |
| 2008 | $2.8B | +19.7% |
| 2007 | $2.3B | — |